Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price dropped 1.7% on Monday . The company traded as low as $2.89 and last traded at $2.97, with a volume of 95,773 shares. The stock had previously closed at $3.02.

KTOV has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Kitov Pharmaceuticals Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, June 28th. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Monday, July 11th.

The firm has a 50-day moving average price of $3.08 and a 200 day moving average price of $4.00. The company’s market capitalization is $11.81 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.